BRPI1006850B8 - processo para determinar a susceptibilidade para contrair infecção nosocomial - Google Patents
processo para determinar a susceptibilidade para contrair infecção nosocomialInfo
- Publication number
- BRPI1006850B8 BRPI1006850B8 BRPI1006850A BRPI1006850A BRPI1006850B8 BR PI1006850 B8 BRPI1006850 B8 BR PI1006850B8 BR PI1006850 A BRPI1006850 A BR PI1006850A BR PI1006850 A BRPI1006850 A BR PI1006850A BR PI1006850 B8 BRPI1006850 B8 BR PI1006850B8
- Authority
- BR
- Brazil
- Prior art keywords
- nosocomial infection
- patient
- susceptibility
- evolution
- contracting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2521/00—Reaction characterised by the enzymatic activity
- C12Q2521/10—Nucleotidyl transfering
- C12Q2521/107—RNA dependent DNA polymerase,(i.e. reverse transcriptase)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2545/00—Reactions characterised by their quantitative nature
- C12Q2545/10—Reactions characterised by their quantitative nature the purpose being quantitative analysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2561/00—Nucleic acid detection characterised by assay method
- C12Q2561/113—Real time assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/26—Infectious diseases, e.g. generalised sepsis
Abstract
processo para determinar a susceptibilidade para contrair infecção nosocominal em um paciente e para estabelecer um prognóstico de evolução de síndrome séptica e uso de reagente específico de produto de expressão do gene s100a9 e/ou do gene s100a8. a presente invenção refere-se a um processo para determinar a susceptibilidade para contrair uma infecção nosocomial em um paciente e um processo para estabelecer um prognóstico de evolução de uma síndrome séptica em um paciente, segundo os quais: a) se dispõe de uma amostra biológica do paciente e se extrai material biológico de amostra biológico; b) se dispõe de pelo menos um reagente específico de um produto de expressão de pelo menos um gene-alvo escolhido dentre os genes-alvo s100a9 e s100a8; c) se determina a expressão de pelo menos um dos genes-alvo a100a9 e s100a8, uma superexpressão em relação a um valor limite determinado, sendo uma indicação de uma susceptibilidade para contrair uma infecção nosocomial e uma indicação de um mau prognóstico de evolução de uma síndrome séptica.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0950305 | 2009-01-19 | ||
FR0950306 | 2009-01-19 | ||
FR0950306A FR2941240B1 (fr) | 2009-01-19 | 2009-01-19 | Procede pour determiner la sensibilite d'un patient a contracter une infection nosocomiale. |
FR0950305A FR2941239B1 (fr) | 2009-01-19 | 2009-01-19 | Procede pour determiner la susceptibilite a contracter une infection nosocomiale chez un patient presentant une reponse systemique inflammatoire associee ou non a une infection. |
PCT/FR2010/050070 WO2010082004A1 (fr) | 2009-01-19 | 2010-01-18 | Procedes pour determiner la susceptibilite a contracter une infection nosocomiale chez un patient et pour etablir un pronostic d'evolution d'un syndrome septique |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI1006850A2 BRPI1006850A2 (pt) | 2016-08-09 |
BRPI1006850B1 BRPI1006850B1 (pt) | 2021-04-06 |
BRPI1006850B8 true BRPI1006850B8 (pt) | 2021-07-27 |
Family
ID=42101520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1006850A BRPI1006850B8 (pt) | 2009-01-19 | 2010-01-18 | processo para determinar a susceptibilidade para contrair infecção nosocomial |
Country Status (10)
Country | Link |
---|---|
US (1) | US11299768B2 (pt) |
EP (1) | EP2379752B1 (pt) |
JP (2) | JP5832903B2 (pt) |
KR (2) | KR20180026561A (pt) |
CN (2) | CN103923980B (pt) |
BR (1) | BRPI1006850B8 (pt) |
ES (1) | ES2556771T3 (pt) |
MX (1) | MX2011007624A (pt) |
RU (2) | RU2525707C2 (pt) |
WO (1) | WO2010082004A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2970975B1 (fr) * | 2011-01-27 | 2016-11-04 | Biomerieux Sa | Procede et kit pour determiner in vitro le statut immunitaire d'un individu |
FR2988479B1 (fr) * | 2012-03-23 | 2014-12-19 | Hospices Civils Lyon | Procede de determination de la susceptibilite aux infections nosocomiales |
FR3010792B1 (fr) | 2013-09-18 | 2017-03-17 | Biomerieux Sa | Procede d'evaluation du risque de mortalite chez les patients qui presentent une reponse inflammatoire systemique (sirs) ou des syndromes septiques |
FR3101358A1 (fr) * | 2019-09-27 | 2021-04-02 | Bioaster | Procédé pour déterminer le risque de survenue d’une infection associée aux soins chez un patient |
RU2743453C1 (ru) * | 2020-07-03 | 2021-02-18 | Федеральное Государственное Бюджетное Научное Учреждение "Федеральный Научно-Клинический Центр Реаниматологии И Реабилитологии" (Фнкц Рр) | Способ прогнозирования инфекционных осложнений критических состояний |
KR102501195B1 (ko) | 2020-07-21 | 2023-02-21 | 주식회사 카카오헬스케어 | 병원의 의사결정 장치, 방법, 컴퓨터 판독 가능한 기록매체 및 컴퓨터 프로그램 |
FR3125300A1 (fr) * | 2021-07-19 | 2023-01-20 | Biomerieux | Utilisation du virus torque teno (ttv) en tant que marqueurs pour determiner le risque de complication chez un patient admis au sein d’un etablissement de sante |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4672040A (en) | 1983-05-12 | 1987-06-09 | Advanced Magnetics, Inc. | Magnetic particles for use in separations |
US5750338A (en) | 1986-10-23 | 1998-05-12 | Amoco Corporation | Target and background capture methods with amplification for affinity assays |
ZA899593B (en) | 1988-12-16 | 1990-09-26 | Siska Diagnostics Inc | Self-sustained,sequence replication system |
US5234809A (en) | 1989-03-23 | 1993-08-10 | Akzo N.V. | Process for isolating nucleic acid |
CA2020958C (en) | 1989-07-11 | 2005-01-11 | Daniel L. Kacian | Nucleic acid sequence amplification methods |
FR2663040B1 (fr) | 1990-06-11 | 1995-09-15 | Bio Merieux | Procede de detection d'une sequence nucleotidique selon la technique d'hybridation sandwich. |
DE69324678T2 (de) | 1992-11-27 | 1999-12-09 | Innogenetics Nv | Verfahren zur typisierung von hcv-isolaten |
US6218529B1 (en) * | 1995-07-31 | 2001-04-17 | Urocor, Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer |
FR2749082B1 (fr) | 1996-05-24 | 1998-06-26 | Bio Merieux | Particules superparamagnetiques et monodispersees |
WO1998018931A2 (en) * | 1996-10-31 | 1998-05-07 | Human Genome Sciences, Inc. | Streptococcus pneumoniae polynucleotides and sequences |
ATE217567T1 (de) | 1997-09-19 | 2002-06-15 | Lignocell Holz Biotech | Verfahren zur verbesserung der imprägnierfähigkeit von holz durch vorbehandlung mit pilzen |
FR2773416B1 (fr) | 1998-01-06 | 2000-02-11 | Bio Merieux | Particules magnetiques perfectionnees, leurs procedes d'obtention et leurs utilisations dans la separation de molecules |
FR2777293B1 (fr) | 1998-04-10 | 2000-05-19 | Bio Merieux | Procede d'electro-separation d'un echantillon biologique et dispositif de mise en oeuvre |
FR2781500B1 (fr) | 1998-07-23 | 2000-09-08 | Bio Merieux | Dispositif perfectionne et procede de lyse de micro-organismes |
WO2001098542A2 (en) * | 2000-06-21 | 2001-12-27 | Digene Corporation | Universal collection medium |
CA2432639A1 (en) * | 2000-11-16 | 2002-05-23 | Cemines, Llc | Profiling tumor specific markers for the diagnosis and treatment of neoplastic disease |
US20060068433A1 (en) * | 2004-09-20 | 2006-03-30 | Godfrey Tony E | Multiple mode multiplex reaction quenching method |
DE50103030D1 (de) | 2001-12-04 | 2004-09-02 | Brahms Ag | Verfahren zur Diagnose von Sepsis unter Bestimmung von S100B |
WO2003069349A2 (en) | 2002-02-15 | 2003-08-21 | Clemens Sorg | Method for diagnosis of inflammatory diseases using mrp8/mrp14 |
GB0215509D0 (en) * | 2002-07-04 | 2002-08-14 | Novartis Ag | Marker genes |
US20040152107A1 (en) * | 2002-09-18 | 2004-08-05 | C. Anthony Altar | Gene signature of electroshock therapy and methods of use |
WO2004044142A2 (en) * | 2002-11-05 | 2004-05-27 | The Brigham And Women's Hospital, Inc. | Mesenchymal stem cells and methods of use thereof |
JP2006524803A (ja) | 2003-03-10 | 2006-11-02 | ノバルティス アクチエンゲゼルシャフト | カルシウムタンパク質の測定に基づく骨転移の発生見込みの評価方法 |
EP1611255A2 (de) * | 2003-04-02 | 2006-01-04 | SIRS-Lab GmbH | Verfahren zur erkennung akuter generalisierter entzündlicher zustände (sirs), sepsis, sepsis ähnlichen zuständen und systemischen infektionen |
DE10324997A1 (de) | 2003-06-03 | 2004-12-23 | Switch Biotech Ag | Mrp8/Mrp14 Inhibitoren und ihre Verwendung zur Prävention und/oder Behandlung von hypertrophen Narben und Keloiden |
US8060315B2 (en) * | 2004-07-27 | 2011-11-15 | Carefusion 303, Inc. | Method for measuring the incidence of hospital acquired infections |
US7645575B2 (en) * | 2004-09-08 | 2010-01-12 | Xdx, Inc. | Genes useful for diagnosing and monitoring inflammation related disorders |
EP1844158A4 (en) | 2004-12-06 | 2010-09-08 | Univ Johns Hopkins | BIOMARKERS FOR INFLAMMATORY INTESTINAL DISEASE |
US20070092911A1 (en) * | 2005-10-03 | 2007-04-26 | Buechler Kenneth F | Methods and compositions for diagnosis and /or prognosis in systemic inflammatory response syndromes |
WO2006122723A1 (en) * | 2005-05-19 | 2006-11-23 | Vaecgene Biotech Gmbh | Method for the prevention and/or treatment of autoimmune disease or allogeneic transplant rejections |
US7732664B2 (en) * | 2006-03-08 | 2010-06-08 | Universidade De Sao Paulo - Usp. | Genes associated to sucrose content |
JP2009530423A (ja) * | 2006-03-21 | 2009-08-27 | ワイス | アミロイド生成性疾患を予防および処置するための方法 |
RU2310850C1 (ru) * | 2006-05-02 | 2007-11-20 | Государственное образовательное учреждение высшего профессионального образования "Уральская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО УГМА Росздрава) | Способ прогнозирования послеоперационного нагноения раны |
EP1950310A1 (en) * | 2007-01-23 | 2008-07-30 | Charite-Universitätsmedizin Berlin | Method for risk prediction of a postoperative sepsis in a human |
CN102257387A (zh) * | 2008-10-28 | 2011-11-23 | 巴黎公众助理医院 | 严重脓毒病和败血性休克期间用于快速确定死亡高风险病人的方法和试剂盒 |
US8283131B2 (en) * | 2008-10-28 | 2012-10-09 | Assistance Publique-Hopitaux De Paris | Methods and kits for the rapid determination of patients at high risk of death during severe sepsis and septic shock |
-
2010
- 2010-01-18 US US13/140,678 patent/US11299768B2/en active Active
- 2010-01-18 CN CN201410101355.XA patent/CN103923980B/zh active Active
- 2010-01-18 MX MX2011007624A patent/MX2011007624A/es not_active Application Discontinuation
- 2010-01-18 JP JP2011545785A patent/JP5832903B2/ja active Active
- 2010-01-18 ES ES10707312.4T patent/ES2556771T3/es active Active
- 2010-01-18 EP EP10707312.4A patent/EP2379752B1/fr active Active
- 2010-01-18 KR KR1020187005733A patent/KR20180026561A/ko not_active Application Discontinuation
- 2010-01-18 CN CN201080004721.XA patent/CN102301008B/zh active Active
- 2010-01-18 BR BRPI1006850A patent/BRPI1006850B8/pt active IP Right Grant
- 2010-01-18 KR KR1020117019336A patent/KR101834993B1/ko active IP Right Grant
- 2010-01-18 WO PCT/FR2010/050070 patent/WO2010082004A1/fr active Application Filing
- 2010-01-18 RU RU2011134644/10A patent/RU2525707C2/ru active
-
2014
- 2014-06-03 RU RU2014122607A patent/RU2663724C2/ru active
-
2015
- 2015-06-03 JP JP2015113078A patent/JP6254975B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
BRPI1006850A2 (pt) | 2016-08-09 |
WO2010082004A1 (fr) | 2010-07-22 |
JP2016005453A (ja) | 2016-01-14 |
BRPI1006850B1 (pt) | 2021-04-06 |
JP2012514993A (ja) | 2012-07-05 |
KR20110111491A (ko) | 2011-10-11 |
KR20180026561A (ko) | 2018-03-12 |
EP2379752B1 (fr) | 2015-09-30 |
MX2011007624A (es) | 2011-10-12 |
RU2011134644A (ru) | 2013-02-27 |
CN103923980B (zh) | 2017-01-11 |
US20110250592A1 (en) | 2011-10-13 |
CN102301008B (zh) | 2015-05-13 |
US11299768B2 (en) | 2022-04-12 |
WO2010082004A9 (fr) | 2010-09-30 |
RU2663724C2 (ru) | 2018-08-08 |
KR101834993B1 (ko) | 2018-03-06 |
RU2014122607A (ru) | 2015-12-10 |
JP5832903B2 (ja) | 2015-12-16 |
CN103923980A (zh) | 2014-07-16 |
JP6254975B2 (ja) | 2017-12-27 |
RU2525707C2 (ru) | 2014-08-20 |
EP2379752A1 (fr) | 2011-10-26 |
CN102301008A (zh) | 2011-12-28 |
ES2556771T3 (es) | 2016-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1006850B8 (pt) | processo para determinar a susceptibilidade para contrair infecção nosocomial | |
Moon et al. | Colorimetric detection of SARS-CoV-2 and drug-resistant pH1N1 using CRISPR/dCas9 | |
Sirker et al. | Evaluating the forensic application of 19 target microRNAs as biomarkers in body fluid and tissue identification | |
Whiley et al. | Detection of novel influenza A (H1N1) virus by real-time RT-PCR | |
BR112018069849A2 (pt) | kit, dispositivo e método para a detecção de câncer pancreático precoce ou de lesão precursora do câncer pancreático | |
BR112019008939A2 (pt) | biossensor, método, e, método para sequenciamento de dna. | |
WO2012112970A3 (en) | Methods and compositions for detecting genetic material | |
NZ608384A (en) | Biomarkers of renal injury | |
WO2011142836A3 (en) | Assays for the detection of genotype, mutations, and/or aneuploidy | |
BR112014007214A2 (pt) | predição de evento de risco cardiovascular e utilização do mesmo | |
BR112016029583A2 (pt) | ?kit ou dispositivo para a detecção de câncer esofágico e método de detecção? | |
PH12014502581A1 (en) | Aptamer-based mulitiplexed assays | |
RU2012151273A (ru) | Прогностические маркеры, пригодные для лечения синдрома ломкой х-хромосомы (fxs) | |
EP3543362A3 (en) | Pcr primer set for bacterial dna amplification, kit for detecting and/or identifying bacterial species, and method for detecting and/or identifying bacterial species | |
WO2011103502A3 (en) | Materials and methods for profiling micrornas | |
IN2014CN03508A (pt) | ||
TR201819546T4 (tr) | Numune tür kökeni için tespit yöntemleri. | |
CN103397105B (zh) | 一种检测gii型诺如病毒的试剂盒及其用途 | |
WO2012040500A3 (en) | Direct blood assay for detection of circulating microrna in cancer patients | |
CN104404140A (zh) | 一种microRNA比色传感器的制备与应用 | |
BR112015019425A2 (pt) | Métodos e kits para identificar e ajustar desvio no sequenciamento de amostras de polinucleotídeos | |
EP4306650A3 (en) | Digital analysis of molecular analytes using electrical methods | |
CN101985664B (zh) | 检测a型流感病毒的核苷酸序列和试剂盒 | |
WO2012115493A3 (ko) | 암에 대한 바이오마커 및 이를 이용한 암 진단 | |
ES2684746T3 (es) | Prueba de cribado para detectar la presencia de virus VPH oncogénicos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 3A ANUIDADE. |
|
B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2385 DE 20/09/2016. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/04/2021, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/01/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO |